Publications by authors named "F Buffa"

Article Synopsis
  • - Current biomarkers for assessing the risk of tumor progression in ER-negative breast cancer patients are inadequate, prompting a study on the role of the AIPL1-NUB1 pathway in tumor suppression under hypoxic conditions.
  • - The study found that downregulation of AIPL1 leads to the deactivation of NUB1, observed through in vitro tests using breast cancer cell lines, and analysis of patient samples revealed significant differences in protein expression levels.
  • - Ultimately, lower levels of cytoplasmic NUB1 were linked to poorer overall survival rates in patients, indicating that both NUB1 and AIPL1 may play crucial roles in the prognosis of breast cancer, particularly in ER-negative cases.
View Article and Find Full Text PDF

Ubiquitination is a crucial posttranslational modification required for the proper repair of DNA double-strand breaks (DSBs) induced by ionizing radiation (IR). DSBs are mainly repaired through homologous recombination (HR) when template DNA is present and nonhomologous end joining (NHEJ) in its absence. In addition, microhomology-mediated end joining (MMEJ) and single-strand annealing (SSA) provide backup DSBs repair pathways.

View Article and Find Full Text PDF

Unlabelled: Response to neoadjuvant radiotherapy (RT) in rectal cancer has been associated with immune and stromal features that are captured by transcriptional signatures. However, how such associations perform across different chemoradiotherapy regimens and within individual consensus molecular subtypes (CMS) and how they affect survival remain unclear. In this study, gene expression and clinical data of pretreatment biopsies from nine cohorts of primary rectal tumors were combined (N = 826).

View Article and Find Full Text PDF

Background: It is uncertain which biological features underpin the response of rectal cancer (RC) to radiotherapy. No biomarker is currently in clinical use to select patients for treatment modifications.

Methods: We identified two cohorts of patients (total N = 249) with RC treated with neoadjuvant radiotherapy (45Gy/25) plus fluoropyrimidine.

View Article and Find Full Text PDF

Background: It is important to identify molecular features that improve prostate cancer (PCa) risk stratification before radical treatment with curative intent. Molecular analysis of historical diagnostic formalin-fixed paraffin-embedded (FFPE) prostate biopsies from cohorts with post-radiotherapy (RT) long-term clinical follow-up has been limited. Utilizing parallel sequencing modalities, we performed a proof-of-principle sequencing analysis of historical diagnostic FFPE prostate biopsies.

View Article and Find Full Text PDF